--- title: "Cardiologist Mark Houston: Why the endothelial glycocalyx is so critical" description: Why is the endothelial glycocalyx changing our understanding of vascular health? This essential physiological discovery provides new tools for health. image: https://blog.calroy.com/hubfs/The%20importance%20of%20the%20endothelial%20glycocalyx%2c%20with%20cardiologist%20Mark%20Houston%2c%20MD-low.gif --- Calroy Health Sciences | 1-800-609-6409 [![Arterosil](https://blog.calroy.com/hubfs/ArterOsil_March2020%20Theme/Images/logo.png) ](https://arterosil.com/) - [** ](https://arterosil.com/my-account) - [** ](https://blog.calroy.com/egx-introduction#) - ## Arterosil by Calroy Health Sciences Blog # Cardiologist Mark Houston: Why the endothelial glycocalyx is so critical Posted by [Calroy Health Sciences](https://blog.calroy.com/author/calroy-health-sciences) on Sep 9, 2021 6:00:00 AM New understanding of what protects the endothelium for vascular health In this 2.5-minute video, cardiologist Mark Houston introduces a breakthrough in vascular physiology: the endothelial glycocalyx. Understanding this critical structure offers new treatment avenues for the many individuals with vascular risk factors. ## Key Takeaways - The endothelial glycocalyx protects the endothelium - The endothelial glycocalyx has many important roles, ranging from housing antioxidants to triggering nitric oxide - Damage to the endothelial glycocalyx allows damage to the endothelium - Restoring the endothelial glycocalyx is a clinical priority Learn more with a 20-minute presentation by Dr. Houston's colleague Dr. Burke, detailing further the many roles of the endothelial glycocalyx, current research, and more. ### [![WATCH](https://no-cache.hubspot.com/cta/default/7072026/7da97c23-3135-43f5-8a2a-b2f947ba0133.png)](https://cta-redirect.hubspot.com/cta/redirect/7072026/7da97c23-3135-43f5-8a2a-b2f947ba0133) ##### About Mark Houston, MD, MS, MSc, ABAARM, FACP, FAHA, FASH, FACN, FAARM, DABC Dr. Mark Houston is a Clinical Instructor at George Washington University. He is also Director of the Hypertension Institute and Vascular Biology and Medical Director of the division of  Human Nutrition at St. Thomas Medical Group, St. Thomas Hospital and Health Services in Nashville, TN. He is on the faculty of A4M for the FAARM and the Metabolic Medicine Institute (MMI) and George Washington University, and directs the Cardiovascular modules. He has also published seven best-selling books on vascular function. Dr. Houston has an active clinical practice, teaches, and does clinical research at St. Thomas Medical Group and Hospital. He founded the [Hypertension Institute](http://www.hypertensioninstitute.com) in 2000.   **IMPORTANT NOTICE: The information on this webpage is for licensed healthcare practitioner education only, and is not to be disseminated to the general public.** Topics: [Mark Houston, MD](https://blog.calroy.com/tag/mark-houston-md) ## Arterosil Research Summary  ### **[Free Download](https://arterosil.com/research/) ** Numerous cellular, animal and human studies have been conducted to evaluate the biological activities, mode of mechanisms, and therapeutic benefits of Arterosil, a patent-pending nutraceutical. Studies include: - MRI Carotid Plaque Regression Study - Glycocalyx Regeneration Study - Leukocyte Adhesion Study - Arterial Elasticity Study - Hypertension Study Download Arterosil's Research Summary [here](https://arterosil.com/research/). ### Subscribe Here! ### Recent Posts ### Posts by Tag - [Kristine Burke, MD (4)](https://blog.calroy.com/tag/kristine-burke-md) - [Joel Kahn, MD, FACC (3)](https://blog.calroy.com/tag/joel-kahn-md-facc) - [Samuel Yanuck, DC (3)](https://blog.calroy.com/tag/samuel-yanuck-dc) - [Endothelial glycocalyx (2)](https://blog.calroy.com/tag/endothelial-glycocalyx) - [Jack Wolfson, DO, FACC (2)](https://blog.calroy.com/tag/jack-wolfson-do-facc) - [Mark Houston, MD (2)](https://blog.calroy.com/tag/mark-houston-md) - [Vascular Health (2)](https://blog.calroy.com/tag/vascular-health) - [AASCP (1)](https://blog.calroy.com/tag/aascp) - [George Stokes, MD (1)](https://blog.calroy.com/tag/george-stokes-md) - [Kara Fitzgerald, ND (1)](https://blog.calroy.com/tag/kara-fitzgerald-nd) - [Mark Hyman, MD (1)](https://blog.calroy.com/tag/mark-hyman-md) - [Robert Sheeler, MD (1)](https://blog.calroy.com/tag/robert-sheeler-md) - [Sunny Kim, MD (1)](https://blog.calroy.com/tag/sunny-kim-md) [See all](https://blog.calroy.com/egx-introduction#) ** **These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.* ** **U.S. Patent No. 11,135,238. International Patents Pending.** © 2022 Calroy Health Sciences. All rights reserved. - [![Arterosil](https://blog.calroy.com/hubfs/ArterOsil_March2020%20Theme/Images/logo-footer.png) ](https://arterosil.com) - [![Calroy](https://blog.calroy.com/hubfs/ArterOsil_March2020%20Theme/Images/calroy-logo.jpg) ](http://calroy.com/) **Calroy Health Sciences, LLC**   14362 N Frank Lloyd Wright, Suite 1000 Scottsdale, AZ 85260 1-800-609-6409 1-480-454-5566 (fax)   7325 W Friendly Ave, Ste H Greensboro, NC 27410 1-800-609-6409 1-480-454-5566 (fax)